-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra,Ming-Sound Tsao
Therapeutic Perspective: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation